521 related articles for article (PubMed ID: 18760581)
21. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.
Yu AP; Yang H; Wu EQ; Setyawan J; Mocarski M; Blum S
J Med Econ; 2011; 14(3):315-23. PubMed ID: 21500975
[TBL] [Abstract][Full Text] [Related]
22. Changes in COPD demographics and costs over 20 years.
Blanchette CM; Dalal AA; Mapel D
J Med Econ; 2012; 15(6):1176-82. PubMed ID: 22812689
[TBL] [Abstract][Full Text] [Related]
23. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
24. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
Zhang B; Zhang Y; Yang J; Liu X
Wei Sheng Yan Jiu; 2007 Nov; 36(6):706-10. PubMed ID: 18303632
[TBL] [Abstract][Full Text] [Related]
26. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
Fillit H; Hill JW; Futterman R
Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
[TBL] [Abstract][Full Text] [Related]
27. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
MMWR Surveill Summ; 2002 Aug; 51(6):1-16. PubMed ID: 12198919
[TBL] [Abstract][Full Text] [Related]
28. Economic burden of metastatic bone disease in the U.S.
Schulman KL; Kohles J
Cancer; 2007 Jun; 109(11):2334-42. PubMed ID: 17450591
[TBL] [Abstract][Full Text] [Related]
29. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
Hong YD; Onukwugha E; Slejko JF
J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
[TBL] [Abstract][Full Text] [Related]
30. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
31. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.
Stein BD; Charbeneau JT; Lee TA; Schumock GT; Lindenauer PK; Bautista A; Lauderdale DS; Naureckas ET; Krishnan JA
COPD; 2010 Jun; 7(3):164-71. PubMed ID: 20486814
[TBL] [Abstract][Full Text] [Related]
32. Healthcare costs of COPD in Italian referral centres: a prospective study.
Koleva D; Motterlini N; Banfi P; Garattini L;
Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461
[TBL] [Abstract][Full Text] [Related]
33. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States.
Green PH; Neugut AI; Naiyer AJ; Edwards ZC; Gabinelle S; Chinburapa V
J Insur Med; 2008; 40(3-4):218-28. PubMed ID: 19317331
[TBL] [Abstract][Full Text] [Related]
34. National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005.
Tsai CL; Sobrino JA; Camargo CA
Acad Emerg Med; 2008 Dec; 15(12):1275-83. PubMed ID: 18976335
[TBL] [Abstract][Full Text] [Related]
35. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
36. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
Yu AP; Guérin A; de Leon DP; Ramakrishnan K; Wu EQ; Mocarski M; Blum SI; Setyawan J
Respir Med; 2011 Dec; 105(12):1861-71. PubMed ID: 21807487
[TBL] [Abstract][Full Text] [Related]
37. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
[TBL] [Abstract][Full Text] [Related]
38. Direct medical costs of COPD--an excess cost approach based on two population-based studies.
Menn P; Heinrich J; Huber RM; Jörres RA; John J; Karrasch S; Peters A; Schulz H; Holle R;
Respir Med; 2012 Apr; 106(4):540-8. PubMed ID: 22100535
[TBL] [Abstract][Full Text] [Related]
39. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.
Goodridge D; Lawson J; Duggleby W; Marciniuk D; Rennie D; Stang M
Respir Med; 2008 Jun; 102(6):885-91. PubMed ID: 18313278
[TBL] [Abstract][Full Text] [Related]
40. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
